Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2-associated epilepsy
Robert G. Mealer, James J. Anderson, Sheridan L Smith, Brianna M. Masters, Samuel H. Barth, Kaitlyn D. J. Huizar, Sahibjot Sran, Hyojung Yoon, Amanda Ringland, Savannah Muron, MaryAnn E Bowyer, Alissa M. D’Gama, Annapurna Poduri, Hart G.W. Lidov, Edward Yang, , Tracy A. Bedrosian
This study identifies disrupted O-GalNAc glycosylation as a mechanism and biomarker for SLC35A2-associated epilepsy using mouse models and human tissue analysis.
bioRxiv · Mar 4, 2026 · PreprintNeuroscience